GLP-1 Analogs for Therapy of Multiple Sclerosis (MSGLP): Design, Methods and Rationale of Randomized, Controlled Clinical Trial

被引：0
|
作者：
Imrich, Richard [1 ]
Penesova, Adela [1 ]
Vlcek, Miroslav [1 ]
Radikova, Zofia [1 ]
Havranova, Andrea [1 ]
Siarnik, Pavol [2 ]
Sivakova, Monika [2 ]
Kollar, Branislav [2 ]
Turcani, Peter [2 ]
机构：
[1] Slovak Acad Sci, Biomed Res Ctr, Bratislava, Slovakia
[2] Comenius Univ, Dept Neurol 1, Fac Med, Bratislava, Slovakia
来源：
NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
14
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [1] Rationale and design of a randomized controlled clinical trial of functional electrical stimulation cycling in persons with severe multiple sclerosis
    Pilutti, Lara A.
    Motl, Robert W.
    Edwards, Thomas A.
    Wilund, Kenneth R.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 3 : 147 - 152
  • [2] A Randomized Controlled Clinical Trial of the GLP-1 Agonist ROSE-010 in Appetite Reduction
    Kenny, Enda
    Mansson, Maria
    Samuelson, Per
    Hellstrom, Per
    OBESITY, 2024, 32 : 198 - 198
  • [3] A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia
    Winzeler, Bettina
    Sailer, Clara O.
    Coynel, David
    Zanchi, Davide
    Vogt, Deborah R.
    Urwyler, Sandrine A.
    Refardt, Julie
    Christ-Crain, Mirjam
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (20):
  • [4] Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
    Niu, Xianli
    Nong, Shirong
    Zhang, Xiaomin
    Li, Xiangyang
    Wang, Cheng
    Li, Wei
    Zhou, Tianhong
    RSC ADVANCES, 2020, 10 (08) : 4725 - 4732
  • [5] Behavior therapy for pediatric trichotillomania: Rationale and methods for a randomized controlled trial
    Morris, Sarah H.
    Kratz, Hilary E.
    Burke, Diana Antinoro
    Zickgraf, Hana F.
    Coogan, Catherine
    Woods, Doug
    Franklin, Martin E.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2016, 9 : 116 - 124
  • [6] Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis
    Motl, Robert W.
    Pilutti, Lara A.
    Sandroff, Brian M.
    Klaren, Rachel
    Balantrapu, Swathi
    McAuley, Edward
    Sosnoff, Jacob J.
    Fernhall, Bo
    CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 151 - 158
  • [7] LIPOIC ACID AND MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
    Khalili, Mohammad
    Eskandari, Ghazaleh
    Ghajarzadeh, Mahsa
    Azimi, Amirreza
    Eghtesadi, Shahryar
    Sahraian, Mohamad Ali
    Motevalian, Abbas
    Hashemi, Hasan
    Mirshafiey, Abbas
    Norouzi, Abbas
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2012, 10 (02) : 95 - 99
  • [8] CLINICAL CONTROLLED RANDOMIZED TRIAL OF AZATHIOPRINE IN MULTIPLE-SCLEROSIS
    GHEZZI, A
    DIFALCO, M
    LOCATELLI, C
    ZAFFARONI, M
    CAPUTO, D
    MARFORIO, S
    CAZZULLO, CL
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 345 - 346
  • [9] Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
    Blonde, Lawrence
    Rosenstock, Julio
    Del Prato, Stefano
    Henry, Robert
    Shehadeh, Naim
    Frias, Juan
    Niemoeller, Elisabeth
    Souhami, Elisabeth
    Li, Chen
    Aroda, Vanita R.
    DIABETES CARE, 2019, 42 (11) : 2108 - 2116
  • [10] Effects of GLP-1 Receptor Agonist on Chronic Axonal Damage, Neurodegeneration, and Cognitive Function in Relapsing-remitting MS (MSGLP): Exploratory, Open Label, Randomized Controlled Trial
    Imrich, Richard
    Penesova, Adela
    Vlcek, Miroslav
    Radikova, Zofia
    Havranova, Andrea
    Siarnik, Pavol
    Hardonova, Miroslava
    Kollar, Branislav
    Turcani, Peter
    NEUROTHERAPEUTICS, 2024, 21 (04)
12345